In-vitro activity of cefotaxime against clinical isolates of Yersinia enterocolitica biotype 4, serotype 03.
Gahrn-Hansen
B
B
Søgaard
P
P
D000368:Aged; D000369:Aged, 80 and over; D002439:Cefotaxime / Q000494:pharmacology* / Q000627:therapeutic use; D006801:Humans; D008826:Microbial Sensitivity Tests; D018805:Sepsis / Q000188:drug therapy; D015008:Yersinia enterocolitica / Q000187:drug effects*; D001618:beta-Lactamases / Q000032:analysis
D001618:beta-Lactamases; D002439:Cefotaxime